Pharmaceutical composition containing a cholesterol absorption inhibitor
CN102285906A
Process for preparation of ezetimibe and derivatives thereof
EP2050440A1
Stable solid pharmaceutical composition comprising candesartan or pharmaceutically acceptable forms thereof
EP2002825A1
Pharmaceutical compositions comprising orlistat
EP1889844A2
Polymorphic forms of ziprasidone sulphates
EP1972335A1
Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
EP1953140A1
Process for the preparation of ezetimibe and derivatives thereof
EP1908748A1
Process for the preparation of memantine and its hydrochloric acid salt form
EP1887006A1
Polymorphic forms of rosiglitazone base
EP1910343A2
Process for the preparation of olmesartan medoxomil
CZ177094A3
Solid medicinal forms with reliable release of alprazolam active component and process for preparing thereof
HRP940417A2
Solid curative forms with reliable release of alprazolame active substance and a process of the production thereof
SI9300504A
Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
HRP931137A2
Process for the preparation of human stephine b and the mutants thereof
HRP931127A2
Granulated animal food product stable to salinomycine quality salts and a process for the preparation thereof
HRP931139A2
Proces for the preparation of l-alanyl-proline derivates
